IP Library Granted Patent US 11,103,846
Granted Patent B2
US 11,103,846 · App. 16/763,787 · Granted Aug 31, 2021

Method and system for manufacturing of biopharmaceutical products

Inventors: Johan Rosenquist (Uppsala, SE); Daria Donati (Uppsala, SE); Mia Margareta Elisabet Bennemo (Uppsala, SE)
Assignee: Cytiva Sweden AB
B01J19/004B01J4/008B01J19/245B01J2219/0002B01J2219/00011B01J2219/00813
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,103,846
App. No.
16/763,787
Granted
Aug 31, 2021
Kind
B2
Abstract

The present disclosure relates to a volume tailorable manufacturing system for quality assured manufacturing of biosafety level classified biopharmaceutical products and a method for tailoring a production volume capability of a manufacturing system. The volume tailorable manufacturing system comprises one or more multi-product suites and a control facility configured to control a unidirectional flow in a circulation system of the one or more multi-product suites. The circulation system is configured to interconnect the one or more multi-product suites and comprises separated supply and return systems. The supply system comprising at least one inlet, the return system comprising at least one outlet that is paired with the inlet and provided at a spatially predetermined position from the inlet, and each inlet/outlet pair comprises a seal when not connected to an adjacent multi-product suite.

Claims (28)

1. A volume tailorable manufacturing system for quality assured manufacturing of biopharmaceutical products associated with a biosafety level classification, the volume tailorable manufacturing system comprising two or more multi-product suites and a control facility configured to control a unidirectional flow in a circulation system of the two or more multi-product suites;

wherein the circulation system is configured to interconnect the two or more multi-product suites and wherein the circulation system comprises separated supply and return systems, the supply system comprising at least one inlet, the return system comprising at least one outlet that is paired with the inlet and provided at a spatially predetermined position from the inlet, and the or each inlet/outlet pair comprises a seal when not connected to an adjacent multi-product suite, and

wherein each multi-product suite of the two or more multi-product suites is inter-operationally discrete from the other multi-product suites of the two or more multi-product suites.

2. The volume tailorable manufacturing system of claim 1 , wherein each inlet/outlet pair is prepared for connection to a further inlet/outlet pair of a further multi-product suite and wherein the seal of an inlet/outlet pair is configured to be broken to expand the volume tailorable manufacturing system with the further multi-product suite.

3. The volume tailorable manufacturing system of claim 1 , wherein the or each inlet/outlet pair is prepared for connection to a further inlet/outlet pair of a further multi-product suite and an inlet/outlet pair is configured to be sealed when the connection to the further inlet/outlet pair is discontinued.

4. The volume tailorable manufacturing system of claim 1 , wherein first and second multi-product suites are comprised in the volume tailorable manufacturing system, an inlet/outlet pair of the first multiproduct suite is connected to an inlet/outlet pair of the second multiproduct suite, and the control facility is configured to control a unidirectional flow in a circulation system interconnecting the first and second multi-product suites.

5. The volume tailorable manufacturing system of claim 1 , wherein the supply system is configured as a central spine within a center portion of the volume tailorable manufacturing system and being at least partly enclosed by the one or more multi-product suites; and wherein the return system of each multi-product suite is configured as a passage along a perimeter of the volume tailorable manufacturing system.

6. The volume tailorable manufacturing system of claim 1 , wherein each multi-product suite of the two or more multi-product suites comprises a first communication interface to the supply system and a second communication interface to the return system.

7. The volume tailorable manufacturing system of claim 1 , wherein the biosafety level classification is BioSafetyLevel 2, BSL2.

8. The volume tailorable manufacturing system of claim 5 , wherein the first communication interface comprises a materials delivery interface and the second communication interface comprises a product delivery interface.

9. The volume tailorable manufacturing system of claim 1 , wherein the materials delivery interface and the product delivery interface are provide by means of air locks.

10. The volume tailorable manufacturing system of claim 1 , wherein the materials delivery comprises supply material delivered to a designated multi-product suite in single-use equipment, the supply material comprising customized culture media and/or buffer.

11. The volume tailorable manufacturing system of claim 1 , wherein the two or more multi-product suites are arranged to receive materials delivery of single-use product contact components.

12. The volume tailorable manufacturing system of claim 1 , wherein each multi-product suite of the two or more multi-product suites comprises at least one further communication interface controlled by a control unit in the respective multi-product suite and wherein the at least one further communications interface is arranged to control employee access to/from the respective multi-product suite.

13. The volume tailorable manufacturing system of claim 1 , wherein the two or more multi-product suites are micro modules configured for biopharmaceutical manufacturing, and wherein the separated supply and return systems are connected to a macrostructure comprising a hydration facility and warehouse facility.

14. A method for expanding production volume capability of a manufacturing system for quality assured manufacturing of biopharmaceutical products associated with a biosafety level classification, the manufacturing system comprising a first multi-product suite and a control facility configured to control a unidirectional flow in a circulation system of the first multi-product suite; wherein the circulation system comprises separated supply and return systems, the supply system comprising an inlet, the return system comprising an outlet that is paired with the inlet and provided at a spatially predetermined position from the inlet, and the inlet/outlet pair comprises a seal, the method comprising

arranging a second multi-product suite in a position adjacent to the first multi-product suite so that a spatially predetermined position of an inlet/outlet pair of the second multi-product suite is arranged to mirror the spatially predetermined position of an inlet/outlet pair of the first multi-product suite;

interconnecting the inlet/outlet pair of the first multi-product suite with the inlet/outlet pair of the second multi-product suite; and

breaking the seal of each inlet/outlet pair, and

wherein the first multi-product suite is inter-operationally discrete from the second multi-product suite.

15. The method of claim 14 , wherein the biosafety level classification is BioSafetyLevel 2, BSL2.

16. The method of claim 14 , wherein the interconnecting comprises validating that a connection formed between the inlet/outlet pair of the first multi-product suite and the inlet/outlet pair of the second multi-product suite complies with requirements for quality assured manufacturing of BioSafetyLevel 2, BSL2, classified biopharmaceutical products and breaking the seal following such validation.

17. The method of claim 15 , wherein the quality assured manufacturing of the biopharmaceutical products associated with a biosafety level classification has been validated for each of the first and second multi-product suites and includes validation of respective inlet/outlet pairs, wherein validation of the second multi-product suite is uncorrelated to validation of the first multi-product suite and wherein the validation of respective inlet/outlet pairs comprises pre-validating a connection to be formed.

18. A method for decreasing production volume capability of a manufacturing system for quality assured manufacturing of biopharmaceutical products associated with a biosafety level classification, the manufacturing system comprising two or more multi-product suites and a control facility configured to control a unidirectional flow in a circulation system of the two or more multi-product suites; wherein the circulation system is configured to interconnect the two or more multi-product suites and wherein the circulation system comprises separated supply and return systems and wherein each multi-product suite of the two or more multi-product suites comprises at least one inlet to the supply system and at least one outlet from the return system, wherein the outlet is paired with the inlet and provided at a spatially predetermined position from the inlet, and the two or more multi-product suites are arranged in adjacent positions having the an inlet/outlet pair of a first multi-product suite of the two or more multi-product suites interconnected with an inlet/outlet pair of a second multi-product suite of the two or more multi-product suites; the method comprising:

disconnecting the first and second multi-product suites by sealing the inlet/outlet pair of the first multi-product suite and/or the second multi-product suite; and

adapting the control facility to control a unidirectional flow in the first multi-product suite, and

wherein each multi-product suite of the two or more multi-product suites is inter-operationally discrete from the other multi-product suites of the two or more multi-product suites.

19. The method of claim 18 , further comprising distancing the second multi-product suite from the first multi-product suite by physically relocating the second multi-product suite to a new location.

Assignments (2)
CHANGE OF NAME Recorded Nov 2, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054278/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2020
From: ROSENQUIST, JOHAN; DONATI, DARIA; BENNEMO, MIA
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 052651/0077 →
Priority Claims (1)
GB 1718917 · Nov 16, 2017 · national
Continuity (1)
Related Publication 20200384433A1 · Dec 10, 2020